Atlas Trials

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Clinical trial NCT02055118 · COMPLETED

Trial details

NCT number
NCT02055118
Sponsor
Shire
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hunter Syndrome
Start date
2014-03-24
Primary completion
2017-09-28
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.